Pulse Biosciences, Inc. Operating Lease, Liability, Noncurrent
Pulse Biosciences, Inc. (PLSE) had Operating Lease, Liability, Noncurrent of $5.09 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $5.09M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $5.53M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $5.96M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $6.37M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $5.09M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $5.53M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $5.96M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $6.37M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $6.79M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $7.17M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $7.54M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $7.17M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $7.50M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $7.80M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $8.09M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.37M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $8.64M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $8.90M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $9.14M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $9.38M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $9.62M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $9.83M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $8.09M 10-Q · filed 2024-10-30 | $10.04M 10-K · filed 2022-03-31 |
| 2021-09-30 | $10.24M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $10.45M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $10.63M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $10.81M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $10.99M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $11.16M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $6.69M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $6.72M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $3.67M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.72M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.22M 10-Q · filed 2019-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |